FKBP15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.116700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.264400E-03
Normal-vs-Stage2
1.236040E-02
Normal-vs-Stage3
3.385800E-02
Normal-vs-Stage4
9.856400E-02
Stage1-vs-Stage2
1.740170E-01
Stage1-vs-Stage3
7.321000E-01
Stage1-vs-Stage4
6.139200E-01
Stage2-vs-Stage3
1.413750E-01
Stage2-vs-Stage4
6.167600E-01
Stage3-vs-Stage4
5.727000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.664900E-03
Normal-vs-AfricanAmerican
9.141000E-03
Normal-vs-Asian
1.328230E-01
Caucasian-vs-AfricanAmerican
3.695000E-01
Caucasian-vs-Asian
4.534800E-01
AfricanAmerican-vs-Asian
3.264800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.277100E-03
Normal-vs-Female
1.268490E-02
Male-vs-Female
6.535400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.447640E-02
Normal-vs-Age(41-60Yrs)
3.310400E-02
Normal-vs-Age(61-80Yrs)
3.604400E-03
Normal-vs-Age(81-100Yrs)
4.257800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.862300E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.537200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.558200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.118630E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.126200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.482800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.477500E-03
Normal-vs-Daily Drinker
1.542240E-02
Normal-vs-Weekly Drinker
1.143760E-01
Normal-vs-Occasional Drinker
4.455500E-03
Normal-vs-Social Drinker
3.588400E-02
Non Drinker-vs-Daily Drinker
3.347800E-01
Non Drinker-vs-Weekly Drinker
1.258400E-01
Non Drinker-vs-Occasional Drinker
4.479600E-01
Non Drinker-vs-Social Drinker
8.038600E-03
Daily Drinker-vs-Weekly Drinker
4.620200E-01
Daily Drinker-vs-Occasional Drinker
8.374400E-01
Daily Drinker-vs-Social Drinker
8.079900E-02
Weekly Drinker-vs-Occasional Drinker
3.614400E-01
Weekly Drinker-vs-Social Drinker
5.159200E-01
Occasional Drinker-vs-Social Drinker
3.345900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.492600E-01
Normal-vs-Grade 2
9.513200E-01
Normal-vs-Grade 3
8.999200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.165690E-02
Grade 1-vs-Grade 3
3.963000E-03
Grade 1-vs-Grade 4
9.492600E-01
Grade 2-vs-Grade 3
1.274240E-01
Grade 2-vs-Grade 4
9.513200E-01
Grade 3-vs-Grade 4
8.999200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.516600E-03
Normal-vs-NonDiabetic
9.383700E-03
Diabetic-vs-NonDiabetic
2.399000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.176300E-02
Normal-vs-NoPancreatitis
5.944600E-03
Pancreatitis-vs-NoPancreatitis
4.307000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.881300E-03
Normal-vs-N1
1.367550E-02
N0-vs-N1
4.987800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.100400E-03
Normal-vs-TP53-NonMutant
1.977140E-03
TP53-Mutant-vs-TP53-NonMutant
1.341550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
